HomeNGENF • OTCMKTS
add
NervGen Pharma Corp
Nakaraang pagsara
$2.12
Sakop ng araw
$2.08 - $2.17
Sakop ng taon
$1.20 - $2.99
Market cap
217.33M CAD
Average na Volume
75.83K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (CAD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 7.16M | 109.51% |
Net na kita | -5.23M | -21.46% |
Net profit margin | — | — |
Kita sa bawat share | -0.07 | — |
EBITDA | -7.14M | -111.35% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CAD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 21.01M | 42.09% |
Kabuuang asset | 22.46M | 37.28% |
Kabuuang sagutin | 13.28M | 18.02% |
Kabuuang equity | 9.18M | — |
Natitirang share | 70.31M | — |
Presyo para makapag-book | 16.27 | — |
Return on assets | -71.07% | — |
Return on capital | -163.03% | — |
Cash Flow
Net change in cash
| (CAD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -5.23M | -21.46% |
Cash mula sa mga operasyon | -5.75M | -302.52% |
Cash mula sa pag-invest | 25.23K | 118.22% |
Cash mula sa financing | 269.74K | 272.66% |
Net change in cash | -5.55M | -327.95% |
Malayang cash flow | -5.10M | -741.40% |
Tungkol
Itinatag
2017
Headquarters
Website
Mga Empleyado
10
